J. Scott Wolchko
2018
In 2018, J. Scott Wolchko earned a total compensation of $3.5M as President, Chief Executive Officer and Director at Fate Therapeutics, a 171% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $258,000 |
|---|---|
| Option Awards | $2,756,998 |
| Salary | $516,000 |
| Total | $3,530,998 |
Wolchko received $2.8M in option awards, accounting for 78% of the total pay in 2018.
Wolchko also received $258K in non-equity incentive plan and $516K in salary.
Rankings
In 2018, J. Scott Wolchko's compensation ranked 3,217th out of 14,244 executives tracked by ExecPay. In other words, Wolchko earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,217 out of 14,244 | 77th |
Division Manufacturing | 1,195 out of 5,765 | 79th |
Major group Chemicals And Allied Products | 414 out of 2,128 | 81st |
Industry group Drugs | 342 out of 1,817 | 81st |
Industry Biological Products, Except Diagnostic Substances | 74 out of 339 | 78th |
Source: SEC filing on March 22, 2019.
Wolchko's colleagues
We found three more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2018.